Richard H. Bell
University of Nottingham(GB)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Surgical Simulation and Training, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer(2005)5,074 cited
- → 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial(2007)1,506 cited
- → Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma(1996)1,088 cited
- → 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial(2017)1,014 cited
- → 13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia(1986)827 cited
- → Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial(2011)611 cited